We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 106 results
  1. The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?

    Epilepsy, a prevalent neurological disease characterized by spontaneous recurrent seizures (SRS), is often refractory to treatment with anti-seizure...

    Wolfgang Löscher in Neurochemical Research
    Article 08 August 2016
  2. Lijst van Geneesmiddelen

    Het ureum bevat een niet-radioactief stabiel koolstofisotoop (koolstof 13). Toegepast als ademtest bij de in-vivo diagnostiek van het vermoeden van...
    J. M. A. Sitsen, H. Abdullah-Koolmees in Geneeskundig jaarboek 2020
    Chapter 2019
  3. Antiepileptic Activity

    Epilepsy is a disease of high prevalence, known for thousands of years as “morbus sacer.” In spite of intensive investigations, the pathophysiology...
    Living reference work entry 2017
  4. Synthesis, anticonvulsant activity and QSAR studies of some new pyrazolyl pyridines

    Twenty-one new 3,5-bipyridinyl-1 H -pyrazole derivatives (pyrazolyl pyridines) have been synthesized and evaluated for their anticonvulsant activity in...

    Joohee Pradhan, Anju Goyal in Medicinal Chemistry Research
    Article 28 May 2016
  5. Synaptic Vesicle Protein 2A as a Novel Pharmacological Target with Broad Potential for New Antiepileptic Drugs

    In recent years, synaptic vesicle protein 2A (SV2A) has become an attractive protein to study due to its important role in epilepsy. This protein is...
    Luz Adriana Pichardo-Macías, Itzel Jatziri Contreras-García, ... Julieta G. Mendoza-Torreblanca in Antiepileptic Drug Discovery
    Protocol 2016
  6. Levetiracetam Prevents Perforin Mediated Neuronal Injury Induced by Acute Cerebral Ischemia Reperfusion

    The purpose of this study is to explore the neuroprotection mechanism of levetiracetam (LEV) with acute focal cerebral ischemia-reperfusion (I/P)...

    Yue Zhang, Ying Li, ... Gang Li in Molecular Neurobiology
    Article 10 October 2015
  7. Synthesis and anticonvulsant activity of new N-phenyl-2-(4-phenylpiperazin-1-yl)acetamide derivatives

    Twenty-two new N -phenyl-2-(4-phenylpiperazin-1-yl)acetamide derivatives have been synthesized and evaluated for their anticonvulsant activity in...

    Krzysztof Kamiński, Beata Wiklik, Jolanta Obniska in Medicinal Chemistry Research
    Article Open access 10 March 2015
  8. Synthesis, biological evaluation and molecular docking studies of thiazole-based pyrrolidinones and isoindolinediones as anticonvulsant agents

    Abstract

    A series of new 1-(thiazol-2-yl)pyrrolidin-2-one 5a m and 2-(thiazol-2-yl)isoindoline-1,3-dione 6a n derivatives were synthesized and...

    Hazem A. Ghabbour, Adnan A. Kadi, ... Hussein I. El-Subbagh in Medicinal Chemistry Research
    Article 28 April 2015
  9. Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective

    Purpose

    Network meta-analysis (NMA) is a new technique that allows multiple treatment comparisons and provides estimates of effect sizes for all...

    Gaetano Zaccara, Fabio Giovannelli, ... Josemir W. Sander in European Journal of Clinical Pharmacology
    Article 28 March 2014
  10. Treatment of Myoclonus

    Myoclonus creates significant disability for patients. This symptom or sign can have many different etiologies, presentations, and pathophysiological...

    John N. Caviness in Neurotherapeutics
    Article 14 September 2013
  11. Effects of Marketed Antiepileptic Drugs and Placebo in the Human Photosensitivity Screening Protocol

    A study of epilepsy patients with a reproducible range of photoparoxysmal responses (PPR) (epileptiform discharges evoked by flashing lights) has...

    Jacqueline A. French, Gregory L. Krauss, ... Emilia Bagiella in Neurotherapeutics
    Article 18 December 2013
  12. Expression of SV2 isoforms during rodent brain development

    Background

    SV2A, SV2B and SV2C are synaptic vesicle proteins that are structurally related to members of the major facilitator superfamily (MFS). The...

    Julie Crèvecœur, Patrik Foerch, ... Bernard Rogister in BMC Neuroscience
    Article Open access 09 August 2013
  13. The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments

    A major goal of contemporary epilepsy research is the identification of therapies to prevent the development of recurrent seizures in individuals at...

    Rafal M. Kaminski, Michael A. Rogawski, Henrik Klitgaard in Neurotherapeutics
    Article 27 March 2014
  14. New avenues for anti-epileptic drug discovery and development

    Despite the introduction of over 15 third-generation anti-epileptic drugs, current medications fail to control seizures in 20–30% of patients....

    Wolfgang Löscher, Henrik Klitgaard, ... Dieter Schmidt in Nature Reviews Drug Discovery
    Article 20 September 2013
  15. γ-Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation

    A new series, of γ-amino butyric acid analogs were designed and synthesized as novel potent GABA-AT inhibitors. A structure–activity relationship...

    S. K. Bansal, B. N. Sinha, R. L. Khosa in Medicinal Chemistry Research
    Article 20 March 2012
  16. Weight-Reducing Side Effects of the Antiepileptic Agents Topiramate and Zonisamide

    Drug-induced weight alteration can be a serious side effect that applies to several therapeutic agents and must be referred to in the respective...
    J. Antel, J. Hebebrand in Appetite Control
    Chapter 2012
  17. The anticonvulsants market

    Charlotte Mackey in Nature Reviews Drug Discovery
    Article 01 April 2010
  18. Key factors in the discovery and development of new antiepileptic drugs

    Since the early 1990s, many new antiepileptic drugs (AEDs) that offer appreciable advantages in terms of their favourable pharmacokinetics, improved...

    Meir Bialer, H. Steve White in Nature Reviews Drug Discovery
    Article 01 January 2010
  19. New Antiepileptic Drugs in Neuropsychiatric Disorders – Basic Mechanisms Related to Clinical Efficacy

    This chapter will cover basic mechanisms of action and correlates to clinical efficacy of recent advances of new antiepileptic drugs (AEDs) in...
    Cecilie Johannessen Landmark, Svein I. Johannessen in Brain Protection in Schizophrenia, Mood and Cognitive Disorders
    Chapter 2010
Did you find what you were looking for? Share feedback.